|
ACRV Acrivon Therapeutics Inc 1781174 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-19,042,000.00 |
| Balance Sheet |
|
Current Assets
|
$99,220,000.00 |
|
Assets
|
$107,832,000.00 |
|
Current Liabilities
|
$11,054,000.00 |
|
Liabilities
|
$12,317,000.00 |
|
Equity
|
$95,515,000.00 |
|
Shares Out
|
38745032.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-20,538,000.00 |
|
Investing Cash Flow
|
$13,127,000.00 |
| Market Analysis |
Market Cap
|
$58,892,448.64 |
|
Price
|
$1.50 |
|
BVPS
|
2.47 |
|
PB
|
0.62 |
|
EPS
|
-0.49 |
|
FCF
|
$-20,552,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACRV documents filed with the SEC.
ACRV Filings
Clear
